In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor

Veterinary Journal

Volumn 178, Issue 1, 2008, Pages 70-77

  Arends, Brigitte ^a   Spee, Bart ^a,d   Hoffmann, Gaby ^a   Jansen, Georgina E G ^a   Slump, Estel ^a   Auriemma, Edoardo ^a   IJzer, Jooske ^b   Hemrika, Wieger ^b   Romijn, Roland A ^b   van der Heijden Liefkens, Karin H A ^c   Sondermeijer, Paul J A ^c   van den Ingh, Ted S G A M ^a   Penning, Louis C ^a   Rothuizen, Jan ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c INTERVET INTERNATIONAL BV   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

c MET; Dogs; ERK1 2; HGF; Liver regeneration; Partial hepatectomy; PCNA; PKB

Indexed keywords

CASPASE 3; CELL CYCLE PROTEIN; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CELL LINE; CONTROLLED STUDY; DOG DISEASE; EPITHELIUM CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INSECT CELL; LIVER DEVELOPMENT; LIVER DISEASE; LIVER REGENERATION; LIVER WEIGHT; MEDICAL RESEARCH; MITOGENESIS; NONHUMAN; PARTIAL HEPATECTOMY; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL LINE; DOGS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; LIVER; LIVER REGENERATION; ORGAN SIZE; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; RECOMBINANT PROTEINS;

CANIS FAMILIARIS; HEXAPODA;

EID: 50449097294     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.11.002     Document Type: Article

References (43)

1. Balkovetz D.F. Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis. Microscopy Research and Technique 43 (1998) 456-463
2. Borowiak M., Garratt A.N., Wustefeld T., Strehle M., Trautwein C., and Birchmeier C. Met provides essential signals for liver regeneration. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 10608-10613
3. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., et al. Identification of the hepatocyte growth factor receptor as the c-MET proto-oncogene product. Science 251 (1991) 802-804
4. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research 47 (1987) 936-942
5. Fan G., Kren B.T., and Steer C.J. Regulation of apoptosis-associated genes in the regenerating liver. Seminars in Liver Disease 18 (1998) 123-140
6. Fukuta K., Matsumoto K., and Nakamura T. Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor. Biochemical Journal 388 (2005) 555-562
7. Funakoshi H., and Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clinica Chimica Acta 327 (2003) 1-23
8. Ido A., Moriuchi A., Kim I., Numata M., Nagata-Tsubouchi Y., Hasuike S., et al. Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatology Research 30 (2004) 175-181
9. Ishiki Y., Ohnishi H., Muto Y., Matsumoto K., and Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16 (1992) 1227-1235
10. Jin H., Wyss J.M., Yang R., and Schwall R. The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure. Current Pharmaceutical Design 10 (2004) 2525-2533
11. Kobayashi Y., Hamanoue M., Ueno S., Aikou T., Tanabe G., Mitsue S., et al. Induction of hepatocyte growth by intraportal infusion of HGF into beagle dogs. Biochemical Biophysical Research Communications 220 (1996) 7-12
12. Kosai K., Matsumoto K., Funakoshi H., and Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30 (1999) 151-159
13. Kost T.A., Condreay J.P., and Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nature Biotechnology 23 (2005) 567-575
14. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. American Journal of Physiology- Renal Physiology 287 (2004) F7-F16
15. Liu Z.M., Zhao H.L., Xue C., Deng B.B., Zhang W., Xiong X.H., et al. Secretory expression and characterization of a recombinant-deleted variant of human hepatocyte growth factor in Pichia pastoris. World Journal of Gastroenterology 11 (2005) 7097-7103
16. Ma P.C., Maulik G., Christensen J., and Salgia R. c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Reviews 22 (2003) 309-325
17. Maina F., and Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nature Neuroscience 2 (1999) 213-217
18. Matsuda Y., Matsumoto K., Yamada A., Ichida T., Asakura H., Komoriya Y., et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26 (1997) 81-89
19. Matsumoto K., and Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Critical Reviews in Oncogenesis 3 (1992) 27-54
20. Maulik G., Shrikhande A., Kijima T., Ma P.C., Morrison P.T., and Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine & Growth Factor Reviews 13 (2002) 41-59
21. Miyake M., Saze K., Yaguchi T., Wang J., Suzuta Y., Haga Y., et al. Canine hepatocyte growth factor: molecular cloning and characterization of the recombinant protein. Veterinary Immunology and Immunopathology 95 (2003) 135-143
22. Mori H., Hirabayashi S., Shirasawa M., Sugimura H., and Hata Y. JAM4 enhances hepatocyte growth factor-mediated branching and scattering of Madin-Darby canine kidney cells. Genes Cells 9 (2004) 811-819
23. Moumen A., Ieraci A., Patane S., Sole C., Comella J.X., Dono R., et al. Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner. Hepatology 45 (2007) 1210-1217
24. Nakagami H., Morishita R., Yamamoto K., Taniyama Y., Aoki M., Matsumoto K., et al. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 37 (2001) 581-586
25. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
26. Oda D., Lee S.P., and Hayashi A. Long-term culture and partial characterization of dog gallbladder epithelial cells. Laboratory Investigation 64 (1991) 682-692
27. Rothuizen J. Diseases of the Liver and Biliary Tract (1999), Saunders, London
28. Rothuizen J., and Meyer H.P. History, Physical Examination, and Clinical Signs of Liver Disease (2000), Saunders, Philadelphia
29. Sato M., Kakubari M., Kawamura M., Sugimoto J., Matsumoto K., and Ishii T. The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochemical Pharmacology 59 (2000) 681-690
30. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373 (1995) 699-702
31. Shiota G., Okano J., Kawasaki H., Kawamoto T., and Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 21 (1995) 106-112
32. Spee B., Arends B., van den Ingh T.S.G.A.M., Brinkhof B., Nederbragt H., Ijzer J., et al. Transforming growth factor beta-1 signaling in canine hepatic diseases: new models for human fibrotic liver pathologies. Liver International 26 (2006) 716-725
33. Spee B., Penning L.C., van den Ingh T.S., Arends B., Ijzer J., van Sluijs F.J., et al. Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comparative Hepatology 4 (2005) 7
34. Stella M.C., and Comoglio P.M. HGF: a multifunctional growth factor controlling cell scattering. International Journal of Biochemistry & Cell Biology 31 (1999) 1357-1362
35. Stoker M., and Perryman M. An epithelial scatter factor released by embryo fibroblasts. Journal of Cell Science 77 (1985) 209-223
36. Tajima H., Matsumoto K., and Nakamura T. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Experimental Cell Research 202 (1992) 423-431
37. Ueki T., Kaneda Y., Tsutsui H., Nakanishi K., Sawa Y., Morishita R., et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Medicine 5 (1999) 226-230
38. Wang M.Y., Yang Y.H., Lee H.S., and Lai S.Y. Production of functional hepatocyte growth factor (HGF) in insect cells infected with an HGF-recombinant baculovirus in a serum-free medium. Biotechnology Progress 16 (2000) 146-151
39. Webber E.M., Godowski P.J., and Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 19 (1994) 489-497
40. WSAVA L.S.G. Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases (2006), Saunders/Elsevier, London
41. Xiao G.H., Jeffers M., Bellacosa A., Mitsuuchi Y., Vande Woude G.F., and Testa J.R. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proceedings of the National Academy of Sciences of the Unites States of America 98 (2001) 247-252
42. Yasuda H., Imai E., Shiota A., Fujise N., Morinaga T., and Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24 (1996) 636-642
43. Yee C.J., DeFrances M.C., Bell A., Bowen W., Petersen B., Michalopoulos G.K., et al. Expression and characterization of biologically active human hepatocyte growth factor (HGF) by insect cells infected with HGF-recombinant baculovirus. Biochemistry 32 (1993) 7922-7931